Quist, Sara W.
van Schoonhoven, Alexander V.
Bakker, Stephan J. L.
Pochopień, Michał
Postma, Maarten J.
van Loon, Jeanni M. T.
Paulissen, Jeroen H. J.
Funding for this research was provided by:
Bayer Pharmaceuticals, Netherlands
Article History
Received: 18 August 2023
Accepted: 4 November 2023
First Online: 28 November 2023
Declarations
:
: Not applicable.
: Not applicable.
: MJP reports grants and honoraria from various pharmaceutical companies, all unrelated to this specific work but some originating from companies developing, producing and marketing drugs in the field of CKD and T2D. SWQ, AVvS, SJLB, JHJP, JMTvL, and MP have no interests to declare.